121 related articles for article (PubMed ID: 3892359)
41. Enkephalinase (EC 3.4.24.11) is highly localized to a striatonigral pathway in rat brain.
Pollard H; Llorens-Cortes C; Couraud JY; Ronco P; Verroust P; Schwartz JC
Neurosci Lett; 1987 Jun; 77(3):267-71. PubMed ID: 2441326
[TBL] [Abstract][Full Text] [Related]
42. Effect of cholecystokinin octapeptide on endogenous amino acid release from the rat ventromedial nucleus of the hypothalamus and striatum.
Barnes S; Whistler HL; Hughes J; Woodruff GN; Hunter JC
J Neurochem; 1991 Apr; 56(4):1409-16. PubMed ID: 2002350
[TBL] [Abstract][Full Text] [Related]
43. Enkephalinase from rat kidney. Purification, characterization, and study of substrate specificity.
Malfroy B; Schwartz JC
J Biol Chem; 1984 Dec; 259(23):14365-70. PubMed ID: 6389547
[TBL] [Abstract][Full Text] [Related]
44. Protection of enkephalins from enzymatic degradation utilizing selective metal-chelating inhibitors.
Altstein M; Bachar E; Vogel Z; Blumberg S
Eur J Pharmacol; 1983 Aug; 91(4):353-61. PubMed ID: 6352283
[TBL] [Abstract][Full Text] [Related]
45. The distribution of chromatographic characterization of an amino-terminal fragment of cholecystokinin (CCK) 58 in rat brain.
Beinfeld MC
Biochem Biophys Res Commun; 1985 Mar; 127(3):720-5. PubMed ID: 3985953
[TBL] [Abstract][Full Text] [Related]
46. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
[TBL] [Abstract][Full Text] [Related]
47. Inactivation of neurotensin by rat brain synaptic membranes. Cleavage at the Pro10-Tyr11 bond by endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase.
Checler F; Emson PC; Vincent JP; Kitabgi P
J Neurochem; 1984 Nov; 43(5):1295-301. PubMed ID: 6387047
[TBL] [Abstract][Full Text] [Related]
48. Characterization and inhibition of a cholecystokinin-inactivating serine peptidase.
Rose C; Vargas F; Facchinetti P; Bourgeat P; Bambal RB; Bishop PB; Chan SM; Moore AN; Ganellin CR; Schwartz JC
Nature; 1996 Apr; 380(6573):403-9. PubMed ID: 8602240
[TBL] [Abstract][Full Text] [Related]
49. In vivo studies on the enhancement of cholecystokinin release in the rat striatum by dopamine depletion.
Butcher SP; Varro A; Kelly JS; Dockray GJ
Brain Res; 1989 Dec; 505(1):119-22. PubMed ID: 2611663
[TBL] [Abstract][Full Text] [Related]
50. Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity.
Petkova-Kirova P; Giovannini MG; Kalfin R; Rakovska A
Brain Res Bull; 2012 Dec; 89(5-6):177-84. PubMed ID: 22981453
[TBL] [Abstract][Full Text] [Related]
51. Peptidases involved in the inactivation of exogenous and endogenous enkephalins.
Schwartz JC; de la Baume S; Yi CC; Chaillet P; Marcais-Collado H; Costentin J
J Neural Transm Suppl; 1983; 18():235-43. PubMed ID: 6348211
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical studies of substance P, cholecystokinin-octapeptide and somatostatin in dorsal root ganglia of the rat.
Tuchscherer MM; Seybold VS
Neuroscience; 1985 Feb; 14(2):593-605. PubMed ID: 2581169
[TBL] [Abstract][Full Text] [Related]
53. Metabolism of gastrin and cholecystokinin by endopeptidase 24.11 from the pig stomach.
Bunnett NW; Debas HT; Turner AJ; Kobayashi R; Walsh JH
Am J Physiol; 1988 Nov; 255(5 Pt 1):G676-84. PubMed ID: 3189556
[TBL] [Abstract][Full Text] [Related]
54. Enzymatic degradation of cholecystokinin in the central nervous system.
Deschodt-Lanckman M
Ann N Y Acad Sci; 1985; 448():87-98. PubMed ID: 3896101
[No Abstract] [Full Text] [Related]
55. Studies on the conformation, enzymatic degradation, pharmacological potency, and binding properties in brain tissue of cholecystokinin-8 and new related peptides.
Roques BP; Durieux C; Gacel G; Pélaprat D; Ruiz-Gayo M; Belleney J; Fellion E; Zajac JM; Fournié-Zaluski MC; Daugé V
Ann N Y Acad Sci; 1985; 448():61-75. PubMed ID: 2992350
[No Abstract] [Full Text] [Related]
56. Pig brain contains cholecystokinin octapeptide and several cholecystokinin desoctapeptides.
Eng J; Shiina Y; Pan YC; Blacher R; Chang M; Stein S; Yalow RS
Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6381-5. PubMed ID: 6312456
[TBL] [Abstract][Full Text] [Related]
57. Subcellular distribution of enkephalin-dipeptidyl carboxypeptidase (enkephalinase) in rat brain.
De La Baume S; Patey G; Schwartz JC
Neuroscience; 1981; 6(3):315-21. PubMed ID: 7012665
[No Abstract] [Full Text] [Related]
58. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
Giros B; Gros C; Solhonne B; Schwartz JC
Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
[TBL] [Abstract][Full Text] [Related]
59. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme].
Roques BP
J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752
[TBL] [Abstract][Full Text] [Related]
60. Distribution of [3H]cholecystokinin octapeptide binding sites in the hippocampal region of the rat brain as shown by in vitro receptor autoradiography.
Köhler C; Hallman H; Radesäter AC
Neuroscience; 1987 Jun; 21(3):857-67. PubMed ID: 3627438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
